MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ITRMF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRMF) Ownership - Who owns Iterum Therapeutics?

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
532
P/E Ratio
9.53
Total Cash
11M
Projected Growth
N/A
Total Debt
33.74M
Revenue
390K
Risk (Beta)
6.82
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for ITRMF
Related Blogs
NRXS

NeurAxis (NRXS) Delivers Record Revenue Growth in Q3 2026

EVAX

Evaxion A/S (EVAX): Is a Move to $12 With +300% Upside Realistic?

ZNTL

Zentalis Pharmaceuticals (ZNTL): Analyst Targets Suggest Potential +360% Move to $8

KURA

Kura Oncology (KURA) Readies Q3 2026 Earnings as KOMZIFTI Launch Takes Shape

CANF

CANF vs GNPX: Weighing Two Clinical-Stage Biotech Micro-Caps

View all blogs related to
#Biotechnology
Interesting Articles

What are the Withdrawal Rules for My SEP IRA?

What are Accounting Records?

What is the Rectangle Top (Bearish) Pattern?

What is the foreign earned income exclusion?

What Is a Stock Split?

View all articles
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A